What the Chief Actuary Should Challenge About Growth Targets Without Execution Capacity

The chief actuary is the executive structurally positioned to see the forward profitability impact of growth targets before anyone else-and professionally obligated to flag it. The CEO advocates for growth because it signals strategic success. The CUO advocates for growth because a larger portfolio provides diversification and market presence. The head of strategy advocates for growth because the strategy function exists to identify market opportunities. Among the executive team, only the chief actuary has a professional obligation independent of the growth objective: the obligation to opine on pricing adequacy, reserve adequacy, and the financial soundness of underwriting activities. The chief actuary sees the early-warning data-loss-development patterns diverging for capacity-constrained cohorts, pricing assumptions failing under volume pressure, reserving ranges that should be wider than the standard methodology produces-before that data reaches the CEO or the board. What most chief actuaries lack is not the insight but the mandate, the board-level standing, and the analytical framework to convert those observations into a challenge to the growth assumptions themselves.

Why should the chief actuary be the primary challenger of growth-target assumptions?

The chief actuary's role in the growth-governance process is structurally different from every other executive's role because the actuarial profession's standards impose an independence obligation that commercial functions do not carry. The chief actuary who signs a reserving opinion or a pricing adequacy statement is personally accountable for the accuracy of that opinion, and the professional consequences of getting it wrong create an incentive to challenge assumptions that other executives-whose incentives are aligned with growth-do not share. This structural independence is the chief actuary's primary value to the board: it provides the board with a source of assessment that is not filtered through the commercial agenda. When the chief actuary tells the board that the proposed growth targets carry a material risk of future reserve strengthening, the board should listen differently than when the CEO describes the market opportunity. As explored in our analysis of solvency relief and reinsurance capital, actuarial independence is a regulatory and governance requirement, not a management preference.

The second reason the chief actuary should lead the challenge is that the actuarial function sees the financial consequences of growth decisions earlier than any other function. The reserving team tracks loss development at the most granular level and is typically the first to observe that capacity-constrained cohorts are developing differently from capacity-sufficient cohorts. The pricing team sees the relationship between submission volume and pricing adequacy and knows whether increased volume is being achieved through market opportunity or through acceptance of lower technical margins. This early-warning capability gives the chief actuary a window into growth-quality degradation that other executives lack. The question is whether the chief actuary has the mandate to convert those early-warning observations into challenges to the growth targets creating the degradation. Our exploration of emerging risks in reinsurance examines how early actuarial signals can anticipate portfolio deterioration.

The third reason is that the board's engagement with actuarial opinion carries a governance weight that commercial presentations do not. When the chief actuary presents a quantified assessment of the reserving and earnings consequences of growth targets, the board's risk committee and audit committee engage with an attention they may not give to the CEO's growth presentation. The chief actuary's professional standing, and the board's reliance on actuarial opinion for financial statement accuracy, create a credibility that the organization should deploy deliberately in the growth-governance process. For the broader governance context, see our coverage of enterprise risk and strategic reinsurance.

What goes wrong when the chief actuary does not challenge growth assumptions?

Five governance failures emerge when the chief actuary's challenge role is not exercised. The board approves growth targets without understanding their reserving implications, the pricing function becomes a support function for growth rather than a control function, the reserving function becomes the bearer of bad news years after the decisions were made, the chief actuary's independence becomes compromised by the growth agenda, and the board lacks the actuarial information to distinguish between good growth and bad growth.

1. Why does the board approve growth targets without understanding reserving implications?

When the chief actuary does not present an independent assessment of the reserving implications of growth targets, the board approves those targets based on the premium and market-share narrative without understanding the financial risk being assumed. The board assumes that because the chief actuary did not object, the growth targets are actuarially sound. In many cases, the chief actuary did not object because the chief actuary was not asked-not because there were no grounds for objection. The governance failure is that the board's most important source of independent financial assurance on growth quality is not systematically engaged in the growth-approval process.

The board's approval of growth targets without actuarial assessment is a governance gap that will be exposed when the reserving consequences emerge. The board will ask why it was not informed of the reserving risk, and the answer will be that the chief actuary was not asked to provide the assessment. The board's own governance process-or its absence-will be the subject of the inquiry, and the board's credibility will be damaged by the revelation that it approved growth without engaging the function best positioned to assess its financial consequences.

2. Why does the pricing function become a support function for growth rather than a control function?

When growth targets are aggressive and the chief actuary is not empowered to challenge them, the pricing function comes under pressure to enable rather than constrain growth. Pricing actuaries process higher volumes in less time, accept broker-provided data with less independent validation, and provide summary-level analyses where full technical pricing was previously required. The pricing function shifts from a control function protecting the portfolio's expected profitability to a support function facilitating the achievement of growth targets.

The shift happens gradually and is rarely acknowledged, but it is the mechanism by which pricing adequacy degrades across the portfolio. The chief actuary who is not empowered to challenge growth cannot protect the pricing function from the pressure to enable it. The pricing function's independence is the chief actuary's responsibility, and if the chief actuary cannot defend it, the independence erodes and the pricing quality erodes with it. The treaty pricing analysis described in our treaty pricing agent illustrates how pricing independence protects portfolio quality.

3. Why does the reserving function become the bearer of bad news years later?

When growth targets are set without actuarial challenge, the reserving function inherits the consequences. The chief actuary, who was not asked to challenge the growth assumptions when they were set, is asked to explain why reserves are developing adversely on business written during the growth acceleration. The reserving function becomes the messenger delivering bad news about decisions made years earlier by executives who may no longer be in their roles.

The governance failure is that actuarial challenge is deployed retrospectively-when the damage is done-rather than prospectively-when the growth targets are being set and the challenge could prevent the damage. The chief actuary is in the impossible position of being accountable for the reserving outcome of decisions in which she had no role. The organization's reserving credibility is damaged, and the chief actuary is the public face of that damage, even though the damage was caused by growth decisions she was not invited to challenge.

4. Why does the chief actuary's independence become compromised by the growth agenda?

In organizations where growth is the dominant strategic priority, the chief actuary who consistently challenges growth assumptions may be perceived as an obstacle rather than a safeguard. The chief actuary may face subtle or explicit pressure to moderate challenges, to accept assumptions that are optimistic but within a range of actuarial plausibility, and to prioritize the organization's growth objectives over the actuarial function's independent assessment role.

The erosion of independence is gradual and, in many cases, unintentional. The chief actuary wants to be a constructive member of the executive team, wants to support the organization's strategic objectives, and does not want to be perceived as the person who always says no. Over time, the chief actuary's challenges become softer, the assumptions accepted become more optimistic, and the independence that is the chief actuary's primary value to the board is compromised. The board, which relies on the chief actuary's independence, may not know it has been compromised until the reserving consequences reveal it.

5. Why does the board lack the actuarial information to distinguish good growth from bad growth?

Without the chief actuary's independent assessment, the board receives growth information that is predominantly commercial: premium volumes, market shares, new-cedent counts, and line-of-business diversification metrics. The board lacks the actuarial information that would distinguish between growth achieved through market opportunity at adequate margins and growth achieved through reduced underwriting standards at inadequate margins. The board governs growth as a commercial activity, not as a risk-taking activity, and governs it with less rigor than it applies to catastrophe exposure or asset allocation.

The information gap is the board's governance gap. The board that does not receive actuarial assessment of growth quality is a board that cannot assess whether the growth it is approving is sustainable or whether it is building future reserving problems. The gap persists because the board does not know what it is not receiving, and the chief actuary-who knows what the board needs-has not been given the mandate or the standing to provide it.

The chief actuary is your board's best defense against growth that builds future reserving problems. Give them the mandate to challenge, or accept that the challenge will come from the reserving data years later.

Talk to Our Specialists

Visit Insurnest to build the actuarial governance framework that equips your chief actuary to govern growth quality.

What does the chief actuary need to mount an effective challenge to growth assumptions?

The chief actuary needs more than professional standing. She needs a documented mandate, an analytical framework, board access, and the organizational protection to challenge growth assumptions without fear of executive-level pushback.

Consider Dr. Sarah Okonkwo, the Chief Actuary at a reinsurance group with aggressive growth targets. Sarah's pricing team was at capacity, with turnaround times that had doubled. Her reserving team was observing adverse development in recent underwriting years. When the CEO presented new growth targets, Sarah requested time to prepare an independent actuarial assessment. Her assessment quantified: the expected margin degradation under the implied capacity conditions, the reserving-range widening, the increased earnings volatility, and the actuarial-resource investment required. She presented directly to the board risk committee alongside the CEO's growth proposal, with a recommendation to moderate targets, invest in actuarial capacity, and implement cohort-based profitability tracking. The board, seeing both the commercial case and the actuarial risk, approved her recommendations. That is what every chief actuary should be asking.

• "I need a documented mandate, endorsed by the board, specifying my role in the growth-governance process: the right to receive growth-target proposals with sufficient lead time, the obligation to present an independent assessment to the board, and the authority to require additional analysis or recommend moderation." A mandate that is not documented is a role that can be circumvented, and a circumvented role provides no governance protection.
• "I need growth targets to be stress-tested against actuarial-capacity constraints-what happens to pricing adequacy and reserving reliability if the actuarial team is processing 30%, 50%, or 70% more analyses than sustainable capacity allows?" Stress tests that do not incorporate capacity constraints are tests that assume away the primary risk to growth quality.
• "I need initial loss picks for growth cohorts to include an explicit capacity-condition adjustment, so that business written when actuaries are at 120% capacity utilization gets a different pick than business written at 80% utilization." Capacity-condition adjustments ensure the reserving basis reflects the conditions under which business was written.
• "I need reserve ranges widened for cohorts written under capacity-constrained conditions-if we are less confident in the pricing, we should be less confident in the initial loss picks." Reserve ranges that do not widen for capacity-constrained business are ranges that understate the reserving risk those cohorts carry.
• "I need pricing-actuarial workload metrics reported alongside premium-growth metrics, so the board sees whether growth is being achieved with adequate actuarial support or whether the function is being overwhelmed." The board cannot assess growth quality without seeing the capacity conditions under which the business is being written.
• "I need a direct reporting line to the board risk committee, independent of the CEO and CUO, so I can present my assessment of growth-quality risk without the CEO or CUO framing my message." Independent access is the structural safeguard protecting the chief actuary's ability to challenge without fear of pushback.
• "I need the chief actuary and CUO to present a joint growth-quality assessment to the board annually-a single document setting out both the commercial case and the actuarial risk assessment." Joint assessment ensures challenge is integrated into governance rather than a separate, easily dismissed input.
• "I need pricing-actuarial independence protected by a board-endorsed professional-standards policy stating that pricing actuaries will provide independent assessments and their evaluations will not be influenced by whether those assessments support or challenge growth objectives." The policy provides organizational protection for pricing actuaries to maintain independence under growth pressure.
• "I need to opine annually on the adequacy of the pricing and reserving infrastructure to support planned growth-my opinion letter to the board includes a specific section on actuarial resources, tools, and standards." The annual opinion provides the board with a checkpoint on growth-capacity alignment from the actuarial perspective.
• "I need technology that provides cohort-level data, capacity-condition tracking, and forward projections-converting my professional concerns into quantified financial impacts the board can evaluate. The enterprise reinsurance analytics described in our risk aggregation agent support precisely this analytical capability." Technology converts professional judgment into evidence, and evidence is the currency of board-level governance.

How can reinsurance groups build the chief actuary's growth-governance capability?

Building the chief actuary's capability to govern growth quality requires defining the role, building the analytical framework, protecting independence, and investing in technology. The following six capabilities define the path.

1. How should you define the chief actuary's role in growth governance?

The chief actuary's role should be defined in a board-endorsed charter specifying: the right to receive growth-target proposals with sufficient lead time for independent assessment, the obligation to present that assessment to the CEO and board before targets are approved, the authority to require additional analysis or recommend moderation, and a direct reporting line to the board risk committee for matters where the actuarial implications of growth are not being adequately addressed.

The charter should be communicated to the CEO, CUO, and executive committee, establishing the chief actuary's role as a governance function, not a support function. The charter should be reviewed annually by the board, and the board should satisfy itself that the chief actuary is exercising the role effectively and without interference.

2. How should you build the analytical framework for growth-quality assessment?

The framework should address four questions: what are the expected margins on business written under the capacity conditions the growth targets imply? What is the likely reserving-range impact of less reliable initial loss picks? What is the earnings-volatility impact of a portfolio with a higher proportion of capacity-constrained business? And what is the actuarial-resource investment required to provide adequate support at the target growth rate?

The framework should produce quantified answers, expressed in financial terms the board can evaluate. The framework should be applied to every growth-target proposal above a defined threshold and updated as actual loss development data emerges to validate or refine the projections.

3. How should you protect actuarial independence under growth pressure?

Actuarial independence should be protected through structural, cultural, and policy mechanisms. Structurally, the chief actuary's direct reporting line to the board risk committee. Culturally, the CEO and board consistently communicating that actuarial challenge is a valued contribution to decision quality. Through policy, the organization documenting that pricing and reserving actuaries are expected to provide independent professional assessments and that their evaluations will not be influenced by whether those assessments support growth objectives.

The protection mechanisms should be regularly reviewed to ensure they remain effective. The chief actuary should report to the board risk committee annually on any instances where actuarial independence was challenged or compromised, enabling the committee to intervene if the protection mechanisms are inadequate.

4. How should you build the actuarial team's capacity to support the governance role?

The chief actuary cannot govern growth quality alone. The pricing-actuarial team needs capacity to produce cohort-based analysis, forward profitability projections, and reserving-range scenarios underpinning the chief actuary's assessment. This means investing in actuarial headcount, technology, and process efficiency to create bandwidth for governance activities alongside transactional pricing and reserving work.

The capacity investment should be included in the growth-target proposal, making actuarial capacity a condition of approving growth above defined thresholds. The board should not approve growth that the actuarial function cannot support without the investment that enables that support.

5. How should you build the board's capability to engage with actuarial growth-quality assessments?

Board members may lack deep actuarial expertise. The chief actuary should provide board education sessions explaining: the relationship between capacity conditions and pricing reliability, the implications of wider reserve ranges, the meaning of earnings-volatility projections, and the questions the board should ask. The chief actuary should frame the assessment in terms connecting actuarial concepts to financial outcomes the board governs.

The education should be repeated periodically as board membership changes and as the analytical framework evolves. The board's capability to engage with the chief actuary's assessment determines the value the board derives from it, and investing in that capability is as important as investing in the assessment itself.

6. How should you use technology to sustain the governance capability over time?

The chief actuary's growth-quality assessment requires data and analytics spanning multiple underwriting years, lines, and functional inputs. A platform providing cohort-level loss-development tracking, capacity-condition attribution, forward profitability projections, and reserving-range analysis enables the chief actuary to produce credible, quantified assessments. Technology converts the governance role from a periodic analytical exercise into a continuous management capability informing every growth and capacity decision.

The chief actuary is the board's actuarial conscience on growth. Give them the mandate, the data, and the protection to speak, and the board will govern growth with an information advantage most boards lack.

Talk to Our Specialists

Visit Insurnest to build the actuarial governance framework your growth strategy requires.

What does actuarial governance of growth quality deliver in practice

Return to Dr. Sarah Okonkwo. Three years after establishing her growth-quality challenge framework, the organization's approach to growth governance had been reshaped. Growth targets were no longer presented as commercial propositions awaiting actuarial validation; they were presented as integrated proposals including both the commercial case and the actuarial assessment, with the chief actuary's independent opinion part of the board's decision package. The board had developed capability to engage with the actuarial assessment, asking about capacity-condition adjustments and reserve-range implications it would not have known to ask three years earlier.

The financial impact was evident in reserving experience. Adverse development on capacity-constrained cohorts had been stemmed because cohorts written after the framework carried initial loss picks reflecting the capacity conditions. Reserve ranges had been appropriately widened, meaning subsequent development fell within expected ranges. The organization's reserving credibility with rating agencies and investors improved measurably.

The broader lesson: the chief actuary's governance role is not a constraint on growth but the mechanism ensuring growth is pursued sustainably. When equipped with the mandate, framework, and technology to challenge growth assumptions effectively, the organization grows better, not less. The quality improves because pricing and reserving foundations are more robust, and the board's confidence increases because growth is governed with the same actuarial rigor as the rest of the portfolio.

Actuarial governance of growth quality is a competitive advantage, not a compliance overhead. Build it.

Talk to Our Specialists

Visit Insurnest to equip your chief actuary for the growth-governance challenge.

Conclusion

The chief actuary is the most underutilized governance asset in reinsurance growth-target processes. In organization after organization, the chief actuary validates growth assumptions rather than challenges them, provides technical support rather than independent assessment, and explains adverse development years later rather than prevents it at the point growth targets are set. This wastes actuarial expertise and costs the industry billions in avoidable reserve strengthening.

Correcting this failure requires defining the chief actuary's governance role explicitly, building the analytical framework to support it, protecting independence structurally and culturally, and equipping the chief actuary with technology to produce credible, quantified assessments. The organizations making this investment will have better-governed growth, better-governed portfolios, more stable earnings, and stronger relationships with rating agencies, regulators, and investors who depend on the actuarial function as the ultimate guarantor of financial soundness.

Frequently asked questions

What is the chief actuary's role in governing growth targets?

The chief actuary's role is to provide an independent assessment of whether proposed growth targets can be achieved without compromising pricing adequacy, reserve adequacy, or the actuarial standards underpinning the organization's financial statements.

What specific assumptions should the chief actuary challenge?

Challenge four assumptions: that historical loss ratios from capacity-sufficient conditions apply under constrained conditions, that actuarial pricing capacity scales proportionally with premium growth, that initial loss picks for expanded lines will prove adequate, and that reserving methodologies calibrated on a slower-growing portfolio remain appropriate.

How should the chief actuary communicate capacity-related concerns?

The chief actuary should communicate through quantified projections-presenting forward loss-ratio estimates for capacity-constrained cohorts, reserving-range scenarios, and earnings-volatility implications framed in financial terms the board uses to make decisions.

What is the relationship between growth targets and reserving risk?

Growth targets exceeding execution capacity increase reserving risk because initial loss picks are less reliable, loss-development patterns for new lines are less established, and reserving methodologies calibrated on slower growth may not apply.

How should the chief actuary work with the CUO to govern growth-capacity balance?

The chief actuary and CUO should operate as joint gatekeepers, with the chief actuary providing forward profitability and reserving analysis and the CUO providing underwriting and market assessment, presenting a joint recommendation to the CEO and board.

What metrics should the chief actuary track to monitor growth-quality degradation?

Track: actual versus expected loss-ratio development by cohort and capacity condition, frequency and magnitude of initial-loss-pick revisions, widening of reserve ranges for capacity-constrained cohorts, and correlation between submission-volume spikes and pricing-adequacy deterioration.

How does growth without capacity affect actuarial independence?

It creates pressure on the actuarial function to support growth by providing analyses enabling business writing, rather than providing independent analysis challenging growth assumptions. The chief actuary must protect independence.

Can technology support the chief actuary's governance of growth-capacity balance?

Yes. A platform like Insurnest provides cohort-level loss-development tracking, capacity-condition attribution, and forward profitability projections quantifying the reserving and earnings implications of growth targets under different capacity scenarios.

About the author

Hitul Mistry is the Founder of Insurnest, an InsurTech company that engineers end-to-end technology exclusively for the insurance industry serving carriers, TPAs, MGAs, brokers, and reinsurers across India, the UAE, and the US. With more than a decade of insurance domain experience, he has built systems spanning underwriting automation, AI-powered underwriting intelligence, claims management, rating and quoting, broking and agency platforms, and reinsurance automation across Health/GMC, Group Life, Motor, P&C, and Reinsurance. Insurnest doesn't adapt generic software to insurance; it builds from the workflow up.

Connect with Hitul on LinkedIn.